ATE189742T1 - Test zur diagnose von demenz - Google Patents

Test zur diagnose von demenz

Info

Publication number
ATE189742T1
ATE189742T1 AT96931219T AT96931219T ATE189742T1 AT E189742 T1 ATE189742 T1 AT E189742T1 AT 96931219 T AT96931219 T AT 96931219T AT 96931219 T AT96931219 T AT 96931219T AT E189742 T1 ATE189742 T1 AT E189742T1
Authority
AT
Austria
Prior art keywords
dementia
platelet
individual
sample
test
Prior art date
Application number
AT96931219T
Other languages
English (en)
Inventor
Meir Shinitzky
Michael Deckmann
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Application granted granted Critical
Publication of ATE189742T1 publication Critical patent/ATE189742T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Eye Examination Apparatus (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
AT96931219T 1995-09-29 1996-09-26 Test zur diagnose von demenz ATE189742T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL11546595A IL115465A0 (en) 1995-09-29 1995-09-29 Assay for the diagnosis of dementia
PCT/IL1996/000118 WO1997013152A1 (en) 1995-09-29 1996-09-26 Assay for the diagnosis of dementia

Publications (1)

Publication Number Publication Date
ATE189742T1 true ATE189742T1 (de) 2000-02-15

Family

ID=11068036

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96931219T ATE189742T1 (de) 1995-09-29 1996-09-26 Test zur diagnose von demenz

Country Status (8)

Country Link
US (1) US20030096227A1 (de)
EP (1) EP0856158B1 (de)
AT (1) ATE189742T1 (de)
AU (1) AU6999296A (de)
CA (1) CA2233321A1 (de)
DE (1) DE69606651T2 (de)
IL (2) IL115465A0 (de)
WO (1) WO1997013152A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL122490A0 (en) 1997-12-07 1998-06-15 Yeda Res & Dev Assay for schizophrenia based on skin reaction
WO2006040153A2 (en) * 2004-10-13 2006-04-20 Ablynx N.V. Single domain camelide anti -amyloid beta antibodies and polypeptides comprising the same for the treatment and diagnosis of degenarative neural diseases such as alzheimer's disease
WO2007072922A1 (ja) * 2005-12-22 2007-06-28 Rohm Co., Ltd. 免疫測定装置及び方法
US11237171B2 (en) 2006-02-21 2022-02-01 Trustees Of Tufts College Methods and arrays for target analyte detection and determination of target analyte concentration in solution
US8492098B2 (en) 2006-02-21 2013-07-23 The Trustees Of Tufts College Methods and arrays for target analyte detection and determination of reaction components that affect a reaction
US9012237B2 (en) * 2009-11-17 2015-04-21 Servicios Cientificos Neuroinnovation Limitada Innovative blood platelets biomarker for early diagnosis of alzheimer's disease
CN103026232B (zh) 2010-03-01 2015-02-04 匡特里克斯公司 扩大用于检测分子或颗粒的测定法中的动态范围的方法和系统
US8236574B2 (en) 2010-03-01 2012-08-07 Quanterix Corporation Ultra-sensitive detection of molecules or particles using beads or other capture objects
US9952237B2 (en) 2011-01-28 2018-04-24 Quanterix Corporation Systems, devices, and methods for ultra-sensitive detection of molecules or particles
WO2012142301A2 (en) 2011-04-12 2012-10-18 Quanterix Corporation Methods of determining a treatment protocol for and/or a prognosis of a patients recovery from a brain injury
US9932626B2 (en) 2013-01-15 2018-04-03 Quanterix Corporation Detection of DNA or RNA using single molecule arrays and other techniques

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9007922D0 (en) * 1990-04-07 1990-06-06 Oxford Virology Plc A diagnostic test method
JP3277211B2 (ja) * 1991-11-12 2002-04-22 プラナ・バイオテクノロジー・リミテッド アルツハイマー病の試験方法と治療方法
IL107515A (en) * 1993-11-05 1997-01-10 Yeda Res & Dev Diagnosis of mental disorders
AU695043B2 (en) * 1994-03-01 1998-08-06 Yeda Research And Development Co. Ltd. Assay for the diagnosis of schizophrenia

Also Published As

Publication number Publication date
CA2233321A1 (en) 1997-04-10
DE69606651D1 (de) 2000-03-16
EP0856158B1 (de) 2000-02-09
IL123247A0 (en) 1998-09-24
AU6999296A (en) 1997-04-28
WO1997013152A1 (en) 1997-04-10
EP0856158A1 (de) 1998-08-05
IL115465A0 (en) 1995-12-31
DE69606651T2 (de) 2000-06-15
US20030096227A1 (en) 2003-05-22

Similar Documents

Publication Publication Date Title
ATE128183T1 (de) Peptide und antikörper, die die bindung von blutplättchen verhindern.
ATE530671T1 (de) Verbindungen und verfahren zur diagnose von tuberkulose
ATE189742T1 (de) Test zur diagnose von demenz
ATE339680T1 (de) Verfahren und vorrichtung zur quantitativen bestimmung von teilchen in flüssigkeiten
ATE76301T1 (de) Nachweis aktivierter blutplaettchen mittels antikoerper gegen zelloberflaechenantigene.
EP0792458A4 (de) Verfahren zur unterstützung der diagnose der alzheimerschen krankheit durch messung der amyloid-beta-peptide(x- 41) und tau
CA2235316A1 (en) A method for detecting antipolymer antibodies and a diagnostic test kit for use in aiding the diagnosis of silicone related diseases (srd)
DE69429192D1 (de) Ein verfahren zur bestimmung von kollagenfragmenten in körperflüssigkeiten, ein testkit und mittel zur durchführung des verfahrens, und seine verwendung zur feststellung von mit dem kollagenmetabolismus assoziierten störungen
ATE163481T1 (de) Charakterisierung von störungen der blutplättchenaggregation
DE69941627D1 (de) Für krebs
Van Oeveren et al. Comparison of coagulation activity tests in vitro for selected biomaterials
DE69032112D1 (de) Verfahren zur Isolierung von fetalen Zytotrophoblastzellen
CA2274776A1 (en) Method for analyzing annexin v in urine and use thereof
DE3850249D1 (de) Nachweis von analyt in partikel enthaltenden proben.
EP0386854B1 (de) Immunologische Bestimmung eines Gerinnungsfaktors in einer Probe
EP0669344A3 (de) Monoklonaler Antikörper und seine Verwendung in einem Immunoassay.
EP0563244A4 (en) Human phospholipase activating protein and methods for diagnosis of rheumatoid arthritis
KR870002453A (ko) 프로좀 단백질에 대한 단일항체의 제조방법 및 그를 이용한 프로좀과 관련된 현상의 검출 및 질병의 진단법
DE69025008D1 (de) Verfahren für direkte chemische Bindung des D-Dimers aus einer biologischen Probe zwecks Diagnostik und Überwachung von thrombolytischen und hyperkoagulablen Zuständen
Levine et al. Fast ELISA for measuring serum antibody responses
JPS5994068A (ja) 血中膵ラ氏島細胞膜抗体のロゼット形成法による検出法
ATE389175T1 (de) Verfahren zur prüfung von antigenen, die mit durch mentalen stress bedingten erkrankungen assoziiert sind
Svendsen et al. Difference and ratio plots: simple tools for improved presentation and interpretation of scientific data Unexpected possibilities for the use of the conglutinin binding assay in inflammatory rheumatic diseases
Lown et al. Application of the proteolytic enzyme papain in routine platelet serology
DE3781808D1 (de) Diagnosetestverfahren fuer schweinedysenterie.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties